Intervet
Equine Vaccine
EQUINE RHINOPNEUMONITIS VACCINE
KILLED VIRUS
An inactivated, purified, concentrated, adjuvanted, tissue culture
origin Equine Herpesvirus EHV-1 vaccine.
INDICATIONS: For vaccination of healthy horses 6
months of age or older, as an aid in the prevention of abortion and respiratory
disease associated with Equine Herpesvirus 1 infection.
DOSE: For pregnant mares administer a 2 mL dose
intramuscularly in the 5th, 7th and 9th months of pregnancy. Three doses are
essential for primary immunization. Maiden and barren mares housed or pastured
with pregnant mares should be vaccinated on the same schedule. For primary
immunization against respiratory disease administer three 2 mL doses
intramuscularly at 4 to 6 week intervals. A 2 mL booster dose should be
administered annually and at any time epidemic conditions exist or are reported
and exposure is imminent.
CAUTION: Store at 35° to 45°F (2° to 7°C). Shake
well before using. Use entire contents when first opened (10 doses). Do not
vaccinate within 21 days before slaughter. Local reactions may occur if this
product is given subcutaneously. Inject deep in the muscle only. Anaphylactoid
reactions may occur.
|
CAUTION: Needle is sharp and may cause injury to
self or animals if not handled properly or disposed of properly. |
|
ANTIDOTE: Epinephrine.
PRESERVATIVES: Neomycin, gentamicin and
thimerosal.
*Adjuvant-Intervet's Proprietary Technology
FOR USE IN ANIMALS ONLY
Intervet Inc., Millsboro, DE 19966
1-800-441-8272
www.intervetusa.com
U.S. Veterinary License No. 286
|
|
Code |
|
10 Doses |
Ten 2 mL Syringes with Separate Sterile Needles |
069141 |
06650103 |
10 Doses |
20 mL |
069142 |
06651003 |
NAC No.: 11061313